Markets:

Overview

News

Currencies

International

Treasuries

Abbott Laboratories (NY:ABT)

108.72 +0.91 (+0.85%)

Streaming Delayed Price Updated: 2:59 PM EDT, Aug 10, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Abbott Laboratories

< Previous 1 2

...

25 26 27 28 29 30 31 32 33

...

57 58 Next >

MedTech Giant DexCom Spotlight Is On G7 US Launch, Analyst Forecasts 22% Revenue Gain In 2024 ↗

October 27, 2023

Oppenheimer analyst Steven Lichtman reiterated the Outperform rating on DexCom, Inc.

Via Benzinga

Got $1,000? These 2 Stocks Could Be Bargain Buys for 2023 and Beyond ↗

October 26, 2023

The market has punished them, but don't overlook these stocks.

Via The Motley Fool

Are These 3 Dividend Aristocrats Undervalued Hidden Gems?

October 25, 2023

Dividend aristocrats Caterpillar, NextEra, and Clorox have shown resilience in challenging times. These may offer opportunities as they are trading off highs.

Via MarketBeat

Abbott Laboratories May Soon Launch a Game-Changing New Device in the U.S. ↗

October 24, 2023

Abbott Laboratories is getting into the consumer wearables market.

Via The Motley Fool

10 Health Care Stocks With Whale Alerts In Today's Session ↗

October 23, 2023

Via Benzinga

(ABT) - Analyzing Abbott Laboratories's Short Interest ↗

October 23, 2023

Via Benzinga

Expert Ratings for Abbott Laboratories ↗

October 19, 2023

Via Benzinga

Abbott Laboratories (NYSE: ABT) Highlighted for Surprising Price Action

October 18, 2023

Via Investor Brand Network

Pivotal Week Coming Up: Big Tech Earnings, Geopolitics, Technicals, Treasury Yield... ↗

October 23, 2023

The upcoming quarter GDP is expected to hit 3.7% which has brought the FED dialogue to “higher rates for longer” which might lead us to a recession in 2024. So watch the yield on the 10-year TSY now at...

Via Talk Markets

Topics Economy

The Value Deepens for Medtech Stocks: Reversal Imminent

October 23, 2023

MedTech stocks are performing well and supported by pent-up demand, yet share prices are trading at significant and often historical lows.

Via MarketBeat

Stock Market Struggles As Treasury Yields Soar; Tesla, Nvidia Among Notable Losers: Weekly Review ↗

October 20, 2023

The major indexes saw significant loses as Treasury yields soared.

Via Investor's Business Daily

Abbott Raises Outlook, Boosted By 'Whopping' Growth Of Diabetes Device ↗

October 18, 2023

The company raised the midpoint of its earnings outlook.

Via Investor's Business Daily

Abbott Laboratories's Earnings Outlook ↗

October 17, 2023

Via Benzinga

A Look Into Abbott Laboratories Inc's Price Over Earnings ↗

October 16, 2023

Via Benzinga

7 Blue-Chip Stocks to Buy on the Dip ↗

October 19, 2023

While you can find plenty of ideas swimming in red ink, investors may find greater success with blue-chip stocks to buy on the dip.

Via InvestorPlace

These Analysts Cut Their Forecasts On Abbott After Q3 Results ↗

October 19, 2023

Abbott Laboratories (NYSE: ABT) reported better-than-expected third-quarter results.

Via Benzinga

Abbott Laboratories (ABT) Q3 2023 Earnings Call Transcript ↗

October 18, 2023

ABT earnings call for the period ending September 30, 2023.

Via The Motley Fool

Topics Earnings

Abbott Laboratories, Nasdaq, Spirit AeroSystems And Other Big Stocks Moving Higher On Wednesday ↗

October 18, 2023

U.S. stocks traded lower, with the Dow Jones falling around 50 points on Wednesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Topics Stocks

Abbott Stock Gains On Q3 Performance, 10% Organic Diagnostics Revenue Growth, Raised Annual Outlook ↗

October 18, 2023

Abbott Laboratories (NYSE: ABT) has reported Q3 FY23 adjusted EPS of $1.14, almost similar to $1.15 a year ago, beating the con

Via Benzinga

Abbott Laboratories Unusual Options Activity For October 12 ↗

October 12, 2023

Via Benzinga

Oversold and Overextended, Abbott Laboratories is a Great Buy

October 18, 2023

Abbott Laboratories rises on solid results and guidance; the value and dividend are at the best levels in years, and the sell-side is buying.

Via MarketBeat

US Stocks Set For Weak Open Ahead Of Tesla Q3 Print: Why This Analyst Is Skeptical Of S&P 500 Recovery To Early 2022 High ↗

October 18, 2023

U.S. stocks faced another setback on Wednesday due to uncertainty surrounding interest rates and inflation.

Via Benzinga

Topics Stocks

Amid Israel-Palestine And Ukraine Gas, Gold Up Big, Cathie Wood's ARKK Down Almost 4% - ETF Winners And Losers: Medium-Cap Returns ↗

October 16, 2023

Via Benzinga

Topics ETFs

Earnings Scheduled For October 18, 2023 ↗

October 18, 2023

Companies Reporting Before The Bell • Procter & Gamble (NYSE:PG) is expected to report quarterly earnings at $1.71 per share on revenue of $21.67 billion.

Via Benzinga

Pendulum Swings: Markets Recover Slightly After Friday's Anxious Trading, But Middle East Worries Dominate ↗

October 16, 2023

(Monday market open) Last week gave us a taste of earnings. The meal starts tomorrow and picks up steam as banks, airlines, and health care companies report.

Via Benzinga

Tesla, Netflix Grab Earnings Spotlight This Week As Analysts Divided On Q3 Reporting Season: What's On Investors' Radar? ↗

October 16, 2023

While analysts look forward to the unfolding reporting season with guarded optimism, they are skeptical regarding forward guidance.

Via Benzinga

3 Dividend Growth Stocks You Can Buy and Hold Forever ↗

October 14, 2023

Investors can sit back and let the dividends flow in with these great stocks.

Via The Motley Fool

Over Delivering: Big Banks Beat Expectations After Tough Quarter, But Market Eyes Middle East Warily ↗

October 13, 2023

(Friday market open) Big bank earnings this morning threatened to take a back seat as geopolitical worries helped spark a rally in crude oil and sent more investors fleeing toward the perceived safety...

Via Benzinga

Israel-Hamas War Shakes Middle East, Inflation Reawakens, Oil Surges: The Week In The Markets ↗

October 13, 2023

Higher-than-expected inflation data this week caught markets off guard, and the Israel-Hamas conflict is sending the markets running to safer assets.

Via Benzinga

Topics Economy

As Isreal-Palestine Conflict Escalates, Gold Ticks Up - ETF Winners And Losers: Medium-Cap Returns ↗

October 12, 2023

Via Benzinga

Topics ETFs

< Previous 1 2

...

25 26 27 28 29 30 31 32 33

...

57 58 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.